Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients
- PMID: 28757725
- PMCID: PMC5442895
- DOI: 10.1016/j.tcmj.2016.03.003
Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients
Abstract
Objective: Chronic kidney disease is associated with decreased bone mineral density (BMD). In this study, the relationship between BMD and the fasting serum concentration of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) was evaluated in peritoneal dialysis (PD) patients.
Material and methods: Fasting blood samples were obtained from 52 PD patients. BMD was measured by dual energy X-ray absorptiometry of the lumbar vertebrae (L2-L4). The serum NT-pro-BNP level was measured by an electrochemiluminescence immunoassay.
Results: Ten patients (19.2%) had osteoporosis, 23 patients (44.2%) had osteopenia, and 19 patients had normal BMD. Increased serum NT-pro-BNP (p < 0.001), advanced age (p = 0.012), decreased body mass index (p = 0.006), body height (p = 0.018), and body weight (p = 0.004) were associated with lower lumbar T-scores, but sex, menopausal status, PD modality, diabetes mellitus, and hypertension were not. Multivariate forward stepwise linear regression analysis with adjustment for age, body height, body weight, body mass index, and log-NT-pro-BNP indicated that a high serum level of log-NT-pro-BNP (R2 change = 0.346; p < 0.001) and low body weight (R2 change = 0.208; p < 0.001) were significantly and independently associated with poor lumbar BMD.
Conclusion: A high serum level of NT-pro-BNP and low body weight were associated with poor BMD in PD patients.
Keywords: Bone mineral density; N-terminal pro-B-type natriuretic peptide; Peritoneal dialysis.
Conflict of interest statement
Conflicts of interest: none.
Similar articles
-
The relationship between serum pro-B type natriuretic peptide level and bone mineral density in peritoneal dialysis patients.Medicine (Baltimore). 2023 Sep 22;102(38):e34666. doi: 10.1097/MD.0000000000034666. Medicine (Baltimore). 2023. PMID: 37746986 Free PMC article.
-
N-terminal pro-B-type natriuretic peptide is inversely related to bone mineral density in renal transplant recipients.Transplant Proc. 2014 Dec;46(10):3443-7. doi: 10.1016/j.transproceed.2014.06.077. Transplant Proc. 2014. PMID: 25498069
-
Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.Perit Dial Int. 2006 May-Jun;26(3):360-5. Perit Dial Int. 2006. PMID: 16722030
-
Triceps Skinfold Thickness Is Associated With Lumbar Bone Mineral Density in Peritoneal Dialysis Patients.Ther Apher Dial. 2017 Feb;21(1):102-107. doi: 10.1111/1744-9987.12482. Epub 2016 Oct 27. Ther Apher Dial. 2017. PMID: 27787966
-
Inverse association of serum long-acting natriuretic peptide and bone mineral density in renal transplant recipients.Clin Transplant. 2012 Mar-Apr;26(2):E105-10. doi: 10.1111/j.1399-0012.2011.01575.x. Epub 2011 Dec 29. Clin Transplant. 2012. PMID: 22211802
Cited by
-
High serum leptin level is associated with peripheral artery disease in adult peritoneal dialysis patients.Tzu Chi Med J. 2018 Apr-Jun;30(2):85-89. doi: 10.4103/tcmj.tcmj_8_18. Tzu Chi Med J. 2018. PMID: 29875588 Free PMC article.
-
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).Respir Res. 2024 Jul 13;25(1):274. doi: 10.1186/s12931-024-02902-2. Respir Res. 2024. PMID: 39003487 Free PMC article.
-
Bone mineral density in older patients with chronic heart failure is related to NYHA classification: a retrospective study.Eur Geriatr Med. 2018 Apr;9(2):183-189. doi: 10.1007/s41999-018-0027-5. Epub 2018 Jan 18. Eur Geriatr Med. 2018. PMID: 34654253
-
Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population.BMC Musculoskelet Disord. 2021 Mar 10;22(1):261. doi: 10.1186/s12891-021-04138-3. BMC Musculoskelet Disord. 2021. PMID: 33691659 Free PMC article.
References
-
- Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol. 2011;57:131–40. - PubMed
-
- Gopal DJ, Iqbal MN, Maisel A. Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med. 2011;123:102–13. - PubMed
-
- Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest. 2007;37:350–6. - PubMed
-
- Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int. 2006;69:1945–53. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials